Objective A new mechanical thrombectomy instrument with preliminary clinical application were introduced. Methods Four cases (3 men and one woman; 61-71 years of age, mean age 66) consisting six legs with subacute or chronic occlusion of the femoropopliteal arteries having a course of 75 days to 10 months, were included in this study. All patients were treated with Straub Rotarex System (Straub Rotarex, patent pending. Straub medical, Wangs, Switzerland). Among them 2 cases were caused by atherosclerosis, 1 by emboli and 1 by diabetes mellitus. The lengths of the occluded segments were 3.8-56 cm. Results The thrombi were removed, and the arteries were undergone recanalization. The blood loss was low, amounting to 5-180 ml. Distal emboli formation in 3 legs were treated successfully by thrombsuction or thrombolysis. Conclusion Straub Rotarex System is a new safe and effective mechanical thrombectomy instrument.

OBJECTIVETo produce anti-19-Nortestosterone (NT) monoclonal antibodies and identify their immunological characteristics.

METHODSHybridomas were prepared by fusing NS0 mouse myeloma cells with splenocytes isolated from immunized BALB/c mice. Noncompetitive and competitive indirect ELISA were employed to screen positive cell clones. A caprylic acid ammonium sulphate (CAAP) method was used to purify NT mAb, and the Batty saturation method was used to determine the affinity constant (Kaff).

RESULTSFive hybridoma cell lines, named NT-1, NT-2, NT-3, NT-4, and NT-5, were identified and their corresponding mAbs were of the IgG(1) isotype with a k light chain. The Kaffs of all mAbs were between 2.6 and 4.7 × 10(9) L/mol. The titers and IC(50) values of purified ascite fluids were in the range of (0.64-2.56) × 10(5) and (0.55-1.0) ng/mL, respectively. Of all the cross-reacting steroids, (-NT was the most reactive with the mAbs at 62% with NT-1 mAb and 64% with NT-2 mAb. Negligible cross-reactivity (<0.01%) with other steroids was observed.

CONCLUSIONThe establishment of these hybridomas allows the potential development of a rapid test kit, and may provide an alternative method for the detection of NT residues in food producing animals.

Animals ; Antibodies, Monoclonal ; Antibody Affinity ; Antibody Specificity ; Cell Line ; Female ; Hybridomas ; Mice ; Mice, Inbred BALB C ; Molecular Structure ; Nandrolone ; chemistry ; immunology ; Plasmacytoma ; Reagent Kits, Diagnostic ; Spleen ; cytology

We aimed to investigate the relationship of dietary zinc intake with new-onset hypertension among Chinese adults. A total of 12,177 participants who were free of hypertension at baseline from the China Health and Nutrition Survey were included. Dietary intake was assessed by three consecutive 24-h dietary recalls combined with a household food inventory. Participants with systolic blood pressure ≽ 140 mmHg or diastolic blood pressure ≽ 90 mmHg or diagnosed by a physician or under antihypertensive treatment during the follow-up were defined as having new-onset hypertension. During a median follow-up duration of 6.1 years, 4269 participants developed new-onset hypertension. Overall, the association between dietary zinc intake and new-onset hypertension followed a J-shape (P for non-linearity < 0.001). The risk of new-onset hypertension significantly decreased with the increment of dietary zinc intake (per mg/day: hazard ratio (HR) 0.93; 95% confidence interval (CI) 0.88-0.98) in participants with zinc intake < 10.9 mg/day, and increased with the increment of zinc intake (per mg/day: HR 1.14; 95% CI 1.11-1.16) in participants with zinc intake ≽ 10.9 mg/day. In conclusion, there was a J-shaped association between dietary zinc intake and new-onset hypertension in general Chinese adults, with an inflection point at about 10.9 mg/day.
Adult ; Humans ; Cohort Studies ; Zinc ; Diet ; Hypertension/epidemiology* ; Eating ; China/epidemiology*